Insights & Opinions

Insights, opinions and commentaries from experts in the biobanking field. Contribute an Article

Interview with Jill Mullan, Chief Operating Officer at iSpecimen

Every medical breakthrough starts with the study of afflicted patients, often through their blood, tumor tissue, or other biological material. Thus, it’s critical for the advancement of life science research that scientists can easily procure the human biospecimens they...

How Biobanks Can Support Personalized Medicine

Biobanks should be an integral part of a comprehensive research platform, not exclusively viewed as a service provider or freezer farm managed with excel sheets. For biobanks to be be viewed as a contributing partner and one that can...

Interview with Dr Alison Parry-Jones, Operations Director of Wales Cancer Bank

For this article, Biobanking.com interviewed Alison Parry-Jones (BSc, MA, PhD, MRSC), the Operations Director of the Wales Cancer Bank (WCB). She is responsible for the day to day running of the biobank and is based at the University Hospital...

Interview with Dr. Robert Hewitt, Biosample Hub

The pharmaceutical industry has the infrastructural and financial resources to bring novel drugs and vaccines into the clinic. It would greatly help expedite their timeline if they had access to biobanks at academic institutes, in order to better understand...
Biobank Facilities

Biobank versus Biorepository: What’s in a Name?

Large-scale analysis of study populations may help develop a deeper understanding of the multi-factorial basis of disease and may form the basis for advancement in prevention, diagnosis and  treatment. Biorepositories (or biobanks) are mostly tissue banks that collect and...

Different Projects, Same Biobanking Software

Sponsored content by Software for biobanks, clinical trials, cohorts and biorepositories, although share many common characteristics, are often very specific and personalised. It is important to be able to rely on a software application that can provide the functionality and...
Safety Strategies for Biobanks

Safety for Biobanks: Strategies for Safe COVID-19 Specimens Handling

The COVID-19 pandemic has spread to almost every country around the world. In less than 4 months, this new disease has affected more than 1,800,000 people and caused almost 120,000 deaths. There are no effective treatments or vaccines for...

Technology in Precision Medicine

The field of medicine is ever evolving, with new techniques and treatments being developed for a range of conditions across the spectrum. The way we understand medicine, fields such as diagnostics and treatments, is also changing. Instead of a ‘one...
ISBER Best Practices Recommendations for Biobanks

ISBER Best Practices Recommendations for Biobanks and Biorepositories

Does Your Biorepository Follow ISBER Best Practices Recommendations? Biorepositories provide essential support to biomedical researchers by collecting, processing, storing and distributing millions of biospecimens every year. Biorepository staff must navigate complex international regulatory rules governing the use of biospecimens and...

How the University of California Davis Pathology Biorepository Achieved CAP Accreditation with OpenSpecimen

Sponsored content brought to you by Research in precision medicine requires a continuous supply of high-quality biospecimens. But as the saying goes - “Garbage in garbage out”, meaningful conclusions from the studies can only be drawn when the researchers are...

⭐ Recently Featured

🔥 Popular Posts

X